Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 33, 2018 - Issue 1
Related Research Data
MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond.
Source:
Bentham Science Publishers Ltd.
Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer's Disease.
Source:
Bentham Science Publishers Ltd.
Oxidative Stress Signaling in Alzheimer’s Disease
Source:
Bentham Science Publishers Ltd.
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders.
Source:
Springer Science and Business Media LLC
Design, synthesis and evaluation of novel tacrine–rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease
Source:
Royal Society of Chemistry (RSC)
Tacrine derivatives and Alzheimer's disease.
Source:
Bentham Science Publishers Ltd.
Old and new acetylcholinesterase inhibitors for Alzheimer’s disease
Source:
Informa UK Limited
Alzheimer's Disease: Genes, Proteins, and Therapy
Source:
American Physiological Society
Discovery of new scaffolds from approved drugs as acetylcholinesterase inhibitors
Source:
Royal Society of Chemistry (RSC)
AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease.
Source:
Bentham Science Publishers Ltd.
Discovery of new acetylcholinesterase and butyrylcholinesterase inhibitors through structure-based virtual screening
Source:
Royal Society of Chemistry (RSC)
Advances in metal-induced oxidative stress and human disease
Source:
Elsevier BV
Acetylcholinesterase interaction with Alzheimer amyloid beta.
Source:
Springer US
The cell cycle in Alzheimer disease: a unique target for neuropharmacology.
Source:
Elsevier BV
Neurodegenerative diseases and oxidative stress.
Source:
Springer Science and Business Media LLC
Design, synthesis and bioevaluation of tacrine hybrids with cinnamate and cinnamylidene acetate derivatives as potential anti-Alzheimer drugs
Source:
Royal Society of Chemistry (RSC)
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease.
Source:
Elsevier BV
Tacrine-ferulic acid-nitric oxide (NO) donor trihybrids as potent, multifunctional acetyl- and butyrylcholinesterase inhibitors.
Source:
American Chemical Society (ACS)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.
Source:
Springer Science and Business Media LLC
Tacrine-Trolox Hybrids: A Novel Class of Centrally Active, Nonhepatotoxic Multi-Target-Directed Ligands Exerting Anticholinesterase and Antioxidant Activities with Low In Vivo Toxicity.
Source:
American Chemical Society (ACS)
Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer's Agents: Design, Synthesis and Biological Evaluation.
Source:
MDPI AG
Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases.
Source:
Elsevier B.V.
Cholinesterases: new roles in brain function and in Alzheimer's disease.
Source:
Springer Science and Business Media LLC
Multiple pharmacological approaches on hydroalcoholic extracts from different parts of Cynoglossum creticum Mill. (Boraginaceae)
Source:
Taylor & Francis Ltd
Design, synthesis, in vitro and in vivo evaluation of tacrine–cinnamic acid hybrids as multi-target acetyl- and butyrylcholinesterase inhibitors against Alzheimer's disease
Source:
Royal Society of Chemistry (RSC)
Design, synthesis and in vitro testing of 7-methoxytacrine-amantadine analogues: a novel cholinesterase inhibitors for the treatment of Alzheimer’s disease
Source:
Springer Science and Business Media LLC
Synthesis and in vitro evaluation of 7-methoxy-N-(pent-4-enyl)-1,2,3,4-tetrahydroacridin-9-amine-new tacrine derivate with cholinergic properties.
Source:
Elsevier BV
Cardanol-derived AChE inhibitors: Towards the development of dual binding derivatives for Alzheimer's disease.
Source:
Elsevier BV
Linking provided by
